Stock GLMD GALMED PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Delayed Nasdaq
Other stock markets
 14:32:01 2024-05-31 EDT 		5-day change 1st Jan Change
0.3892 USD +6.89% Intraday chart for Galmed Pharmaceuticals Ltd. +0.46% -14.46%
04-04 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-15 Galmed Pharmaceuticals Ltd. Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of Nash and Liver Fibrosis CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GALMED PHARMACEUTICALS LTD.
Bio Therapeutic Drugs
+6.89%+0.46%-14.46%-91.56%-99.57% 2.19M
Neutral
Neutral
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. GLMD Stock
  4. Charts Galmed Pharmaceuticals Ltd.
  5. Comparison Chart